HCSGD entry for KCNK3
1. General information
Official gene symbol | KCNK3 |
---|---|
Entrez ID | 3777 |
Gene full name | potassium channel, subfamily K, member 3 |
Other gene symbols | K2p3.1 OAT1 TASK TASK-1 TBAK1 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0005252 | Open rectifier potassium channel activity | IEA | molecular_function |
GO:0005267 | Potassium channel activity | TAS | molecular_function |
GO:0005886 | Plasma membrane | TAS | cellular_component |
GO:0005887 | Integral component of plasma membrane | TAS | cellular_component |
GO:0006813 | Potassium ion transport | TAS | biological_process |
GO:0007268 | Synaptic transmission | TAS | biological_process |
GO:0007420 | Brain development | IEA | biological_process |
GO:0008022 | Protein C-terminus binding | IEA | molecular_function |
GO:0022841 | Potassium ion leak channel activity | IDA | molecular_function |
GO:0042493 | Response to drug | IEA | biological_process |
GO:0042803 | Protein homodimerization activity | IEA | molecular_function |
GO:0046982 | Protein heterodimerization activity | IEA | molecular_function |
GO:0051481 | Negative regulation of cytosolic calcium ion concentration | IEA | biological_process |
GO:0071294 | Cellular response to zinc ion | IEA | biological_process |
GO:0071456 | Cellular response to hypoxia | IEA | biological_process |
GO:0090102 | Cochlea development | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.2664630979 | 0.8597217165 | 0.9624317933 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.0982321488 |
GSE13712_SHEAR | Down | -0.4334708657 |
GSE13712_STATIC | Up | 0.1623151748 |
GSE19018 | Up | 0.1257002528 |
GSE19899_A1 | Up | 0.0206775961 |
GSE19899_A2 | Up | 0.1246423976 |
PubMed_21979375_A1 | Up | 0.3675560252 |
PubMed_21979375_A2 | Down | -0.0835978361 |
GSE35957 | Up | 0.2126838343 |
GSE36640 | Up | 0.0341633832 |
GSE54402 | Up | 0.4737673660 |
GSE9593 | Down | -1.0814403282 |
GSE43922 | Up | 0.0964023174 |
GSE24585 | Up | 0.0157572092 |
GSE37065 | Up | 0.1790059288 |
GSE28863_A1 | Up | 0.0236267690 |
GSE28863_A2 | Up | 0.1929745100 |
GSE28863_A3 | Up | 0.0512915732 |
GSE28863_A4 | Up | 0.1527834200 |
GSE48662 | Up | 0.0581367381 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Doxapram | DB00561 | APRD00935 |